Posts
February 19 2024
Venus Concept Inc. announced the closing of its Registered Direct offering in the amount of $1,200,000. EG&S acted as counsel to the Placement Agent.
February 19 2024
The Deal has revealed its global league tables for financial, legal and other deal services providers in M&A for 2023. EGS ranked 24th for legal advisers – having completed 23 total deals with disclosed values of more than $100 million. Congratulations to our Corporate/M&A team for their notable efforts and achievements!
Click here to view the league table.
February 18 2024
Revelation Biosciences, Inc. announced the closing of its Public Offering in the amount of $6,200,000. EG&S acted as counsel to the Placement Agent.
February 17 2024
Draganfly Inc. announced the closing of its Underwritten Public Offering in the amount of $3,600,000. EG&S acted as counsel to the Underwriter.
February 16 2024
Ohmyhome Ltd., a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore, announced the closing of its upsized public offering in the amount of $4,800,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with this offering.
February 15 2024
Evaxion Biotech A/S announced the closing of its Public Offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
February 15 2024
Evaxion Biotech A/S announced the closing of its Public Offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
February 14 2024
CERo Therapeutics, Inc., an immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced the closing of its business combination with Phoenix Biotech Acquisition Corp. The transaction is valued at approximately $50,000,000. EGS acted as counsel to CERo Therapeutics, Inc.
